← SynDRA
CLOFAZIMINE
SynDRA canonical compound SYN0005091 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | GK0582 inhibitor |
|---|
| Indication | leprosy |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
Drug classes
- Antimycobacterial
- Anti-Bacterial Agents
- Anti-Infective Agents
- Anti-Inflammatory Agents
- Leprostatic Agents
ATC classes
- DRUGS FOR TREATMENT OF LEPRA
Cross-references
Synonyms
- LAMPRENE
- lamprene
- chlofazimine
- Clofazimina
- Chlofazimine
- Clofaziminum
- Colfazimine
- G-30320
- G30320
- NSC-141046
- Lamprene
- Lampren
- Clofaziminum [INN-Latin]
- B 663 (Pharmaceutical)
- Clofazimina [INN-Spanish]
- B 663
- UNII-D959AE5USF
- B 663 (VAN)
- C27H22Cl2N4
- EINECS 217-980-2
- CFZ
- SMP2_000339
- B 663, pharmaceutical
- Lamprene (TN)
- Liposome-encapsulated clofazimine
- Clofazimine [USAN:INN:BAN]
- G-30,320
- Clofazimine (JAN/USP/INN)
- Riminophenazine
- NSC 141046
- D959AE5USF
- CHEMBL1083384
- NSC141046
- NCGC00016600-01
- CAS-2030-63-9
- SMR000058704
- SR-05000001807
- BRN 0060420
Look up CLOFAZIMINE in the interactive SynDRA portal →